BOARD CERTIFICATION EXAM STUDY GUIDES Lower Extremity Trauma
[Click on Image to Enlarge]
ME-P Free Advertising Consultation
The “Medical Executive-Post” is about connecting doctors, health care executives and modern consulting advisors. It’s about free-enterprise, business, practice, policy, personal financial planning and wealth building capitalism. We have an attitude that’s independent, outspoken, intelligent and so Next-Gen; often edgy, usually controversial. And, our consultants “got fly”, just like U. Read it! Write it! Post it! “Medical Executive-Post”. Call or email us for your FREE advertising and sales consultation TODAY [770.448.0769]
Medical & Surgical e-Consent Forms
ePodiatryConsentForms.com
iMBA Inc., OFFICES
Suite #5901 Wilbanks Drive, Norcross, Georgia, 30092 USA [1.770.448.0769]. Our location is real and we are now virtually enabled to assist new long distance clients and out-of-town colleagues.
ME-P Publishing
SEEKING INDUSTRY INFO PARTNERS?
If you want the opportunity to work with leading health care industry insiders, innovators and watchers, the “ME-P” may be right for you? We are unbiased and operate at the nexus of theoretical and applied R&D. Collaborate with us and you’ll put your brand in front of a smart & tightly focused demographic; one at the forefront of our emerging healthcare free marketplace of informed and professional “movers and shakers.” Our Ad Rate Card is available upon request [770-448-0769].
Posted on September 21, 2023 by Dr. David Edward Marcinko MBA
By Staff Reporters
Klaviyo, the digital marketing software company popped more than 20% above its IPO price of $30/share during its first day of trading yesterday and ultimately ended the day 9% up. This performance will likely help other tech companies to feel confident enough to go public.
But, for those keeping score of the IPO market at home, this week’s other high-profile, venture-backed market entrant, Instacart, fell yesterday after an initial bump following its Tuesday debut.
Posted on September 21, 2023 by Dr. David Edward Marcinko MBA
By Staff Reporters
***
***
The Federal Reserve announced it was leaving its benchmark interest rate unchanged at a 22-year high on Wednesday but signaled it could hike rates again in its fight to bring down inflation. After a two-day meeting the Fed announced its federal funds rate would remain in a range of 5.25 to 5.5% – the same level as the central bank announced in July, when it last raised rates.
***
Here is where the major benchmarks ended:
The S&P 500 Index was down 41.75 points (0.9%) at 4,402.20; the Dow Jones Industrial Average (DJIA) was down 76.85 points (0.2%) at 34,440.88; the NASDAQ Composite was down 209.06 points (1.5%) at 13,469.13.
The 10-year Treasury note yield (TNX) was up about 3 basis points at 4.393%.
CBOE’s Volatility Index (VIX) was up 1.03 at 15.14, after touching a two-week high.
Communication services and technology were among the weakest sectors Wednesday, with the Philadelphia Semiconductor Index (SOX) falling to its lowest level since late May.
Regional banks were also lower, and energy stocks slipped after crude oil futures pulled back from a recent rally. Real estate and consumer staples posted modest gains. The U.S. Dollar Index (DXY) strengthened back toward a six-month high.